⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ZNTL News
Zentalis Pharmaceuticals, Inc. Common Stock
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
ZNTL
Form 8-K
sec.gov
ZNTL
Zentalis Strengthens Commercial Leadership with Appointments of Shannon Campbell to Board of Directors and Sarah Kelly as SVP of Commercial Strategy
globenewswire.com
ZNTL
Zentalis Pharmaceuticals to Present Phase 1b MUIR Trial Data Showing Encouraging Clinical Activity and Manageable Safety Profile of Azenosertib Plus Paclitaxel in Platinum-Resistant Ovarian Cancer at ASCO 2026
globenewswire.com
ZNTL
Form 8-K
sec.gov
ZNTL
Zilliant Webinar to Unpack Why 62% of Manufacturers and Distributors Are Losing Customers Over Pricing Decisions
businesswire.com
ZNTL
Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences
globenewswire.com
ZNTL
Form 8-K
sec.gov
ZNTL
Zentalis Pharmaceuticals Reports First Quarter 2026 Financial Results and Clinical Progress
globenewswire.com
ZNTL
Form 8-K
sec.gov
ZNTL